Talk:Team:UCL/Modeling

From 2013.igem.org

(Difference between revisions)
(Created page with "<html> <head> <script type="text/javascript" src="https://2013.igem.org/Team:UCL/static/head.js?action=raw&ctype=text/javascript"> </script> <link rel="stylesheet" type="text...")
Line 47: Line 47:
<div class="col_left">
<div class="col_left">
-
<p class="major_title">DRY-LAB</p>
+
<p class="major_title">DRY LAB</p>
<p class="minor_title">Modeling The Treatment And Finding New Parts</p>
<p class="minor_title">Modeling The Treatment And Finding New Parts</p>

Revision as of 13:27, 4 September 2013

DRY LAB

Modeling The Treatment And Finding New Parts

Our project this year blends the fields of synthetic biology and neuroscience. We aim to demonstrate that genetic engineering techniques can be applied to the central nervous system, in order to rectify abnormalities in, for example, the brain on a cellular and/or macromolecular level. Such a novel application of synthetic biology could offer new ways to treat certain brain diseases, such as Alzheimer’s disease, for which modern pharmaceutical treatment is purely symptomatic.

Click the abstracts below to read more.

Treatment Model

Alzheimer’s disease is the most prevalent form of dementia. Symptoms include memory loss, mood fluctuations and problems with communication and reasoning. It is a physical, degenerative condition that causes cell death in the brain.

Bioinformatics

There are many hypotheses on the causes for Alzheimer’s disease, though there are three accepted signs in the brain: plaques, tangles and cell death. We focus on the so called ‘Amyloid Hypothesis’.

Retrieved from "http://2013.igem.org/Talk:Team:UCL/Modeling"